Dave Vellante's Breaking Analysis: The AI Era Brilliantly Advances With Nvidia and Broadcom Stepping On The Gas

Data-driven insights and predictions are the hallmark of SiliconANGLE and theCUBE. From massive tech titans to nascent startups, we empower you with the context needed to make informed investment decisions. This week, Dave Vellante, co-CEO and chief analyst at SiliconANGLE and theCUBE, reflected on two notable corporate events he attended this week: Nvidia's GTC conference and Broadcom's investor day. Vellante explains how the artificial intelligence (AI) platform shift is on full display and how these events highlighted the expanding breadth of AI. He believes that Nvidia and Broadcom are currently the two best-positioned companies to capitalize on the AI wave and will each dominate their respective markets for the better part of a decade. However, he also notes that they are part of a broader ecosystem that collectively will create more value than each company alone. Vellante provides an in-depth analysis of the state of AI and how Nvidia and Broadcom are leading the way with dramatically different but overlapping strategies that may be headed for an eventual collision course. He concludes by teasing next week's episode about AI trends and the ongoing AI platform wars.

This analysis offers a comprehensive overview of the current state of AI and the evolving landscape. It also provides insights into the strategies of Nvidia and Broadcom within the context of the broader AI ecosystem. By considering these factors, readers can make informed decisions regarding the future of AI and the potential opportunities and challenges it presents.

Read more

Prospective observational study of peripheral intravenous cannula utilisation and frequency of intravenous fluid delivery in the emergency department: convenience or necessity?

Introduction Over one billion peripheral intravenous cannulas (PIVCs) are inserted worldwide each year. Insertion of PIVCs is associated with pain, phlebitis, occlusion, and medication extravasation as well as the risk of catheter-associated infection, with an associated cost to departmental resources. Previous studies have not assessed if intravenous (IV) fluid delivery